AI Article Synopsis

  • Smith-Magenis syndrome (SMS) is a neurobehavioral disorder caused primarily by a deletion on chromosome 17p11.2, involving gene haploinsufficiency, particularly of the RAI1 gene.
  • In a study of 36 patients with SMS-like symptoms but without the typical microdeletion, 10 had RAI1 variants, including new mutations, and RAI1 expression levels were notably reduced in those with identifiable mutations.
  • Key clinical features associated with decreased RAI1 expression include ocular issues and object insertion behaviors, suggesting that these characteristics can help identify patients for further genetic testing and potential treatment strategies.

Article Abstract

Smith-Magenis syndrome (SMS) is a complex neurobehavioral disorder characterized by multiple congenital anomalies. The syndrome is primarily ascribed to a ∼3.7 Mb de novo deletion on chromosome 17p11.2. Haploinsufficiency of multiple genes likely underlies the complex clinical phenotype. RAI1 (Retinoic Acid Induced 1) is recognized as a major gene involved in the SMS phenotype. Extensive genetic and clinical analyses of 36 patients with SMS-like features, but without the 17p11.2 microdeletion, yielded 10 patients with RAI1 variants, including 4 with de novo deleterious mutations, and 6 with novel missense variants, 5 of which were familial. Haplotype analysis showed two major RAI1 haplotypes in our primarily Caucasian cohort; the novel RAI1 variants did not occur in a preferred haplotype. RNA analysis revealed that RAI1 mRNA expression was significantly decreased in cells of patients with the common 17p11.2 deletion, as well as in those with de novo RAI1 variants. Expression levels varied in patients with familial RAI1 variants and in non-17p11.2 deleted patients without identified RAI1 defects. No correlation between SNP haplotype and RAI1 expression was found. Two clinical features, ocular abnormalities and polyembolokoilomania (object insertion), were significantly correlated with decreased RAI1 expression. While not significantly correlated, the presence of hearing loss, seizures, hoarse voice, childhood onset of obesity and specific behavioral aspects and the absence of immunologic abnormalities and cardiovascular or renal structural anomalies, appeared to be specific for the de novo RAI1 subgroup. Recognition of the combination of these features will assist in referral for RAI1 analysis of patients with SMS-like features without detectable microdeletion of 17p11.2. Moreover, RAI1 expression emerged as a genetic target for development of therapeutic interventions for SMS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152558PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0022861PLOS

Publication Analysis

Top Keywords

rai1 variants
16
rai1
14
rai1 expression
12
retinoic acid
8
acid induced
8
smith-magenis syndrome
8
17p112 deletion
8
patients sms-like
8
sms-like features
8
novo rai1
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!